p21-activated kinase 1 (PAK1) is a mediator of downstream signaling from the small GTPases Rac and Cdc42. In its inactive state, PAK1 forms a homodimer where two kinases inhibit each other in trans. The kinase inhibitory domain (KID) of one molecule of PAK1 binds to the kinase domain of its counterpart and keeps it inactive. Therefore, the isolated KID of PAK1 has been widely used to specifically inhibit and study PAK function. Here, we show that the isolated KID induced a cell cycle arrest with accumulation of cells in the G1 phase of the cell cycle with an inhibition of cyclin D1 and D2 expression. This cell cycle arrest required the intact KID and was also induced by a mutated KID unable to block PAK1 kinase activity. Furthermore, the KID-induced cell cycle arrest could not be rescued by the expression of a constitutively active PAK1-T423E mutant, concluding that this arrest occurs independently of PAK1 kinase activity. Our results suggest that PAK1 through its KID inhibits cyclin D expression and thereby enforces a cell cycle arrest. Our results also call for serious precaution in the use of KID to study PAK function.
The p21-activated kinase (PAK) family members are serine/threonine protein kinases named by the fact that they can be activated by the small p21-GTPases Rac and Cdc42 (Jaffer and Chernoff, 2002) . Some of the PAKs have been implicated to be involved in cellular transformation. For example, the PAK1 gene is amplified in ovarian and breast cancers (Bekri et al., 1997; Schraml et al., 2003) . Furthermore, invasive breast cancer cells and tumors have increased PAK1 activity. In addition, the kinase-dead dominant-negative PAK1-K299R mutant (dn PAK1) inhibited transformation induced by oncogenic ras whereas a kinase-active T423E PAK1 (ca PAK1) induced anchorage-independent growth in breast epithelial cells (Tang et al., 1997; Vadlamudi et al., 2000) .
As mediators of Cdc42 and Rac signaling, PAKs are involved in the control of cytoskeletal rearrangements such as disassembly of stress fibers and focal adhesion complexes (Manser et al., 1997 Zhao et al., 1998) . These functions might mediate transformation-promoting effects of activated PAK1 leading to invasive motile cells and tumor progression and metastasis. In addition, PAKs have been implicated in the control of cell cycle progression. In particular, the yeast PAK homologues Ste20 and Cla4 in Saccharomyces cerevisiae are primary regulators of cell and actin polarization throughout the cell cycle and are essential for cytokinesis and mitosis (Cvrckova et al., 1995; Holly and Blumer, 1999; Weiss et al., 2000) . Recent studies show that mammalian PAK1 is also involved in the regulation of mitosis (Li et al., 2002; Zhao et al., 2005) . Furthermore, by using inhibitors of PAK1-3, Nheu et al. (2004) showed that PAK activity is essential for renin-angiotensin systeminduced upregulation of cyclin D1 and by preventing PAK1 expression by siRNA, Balasenthil et al. (2004) could reduce cyclin D1 mRNA expression. These findings suggest a role for PAK1 in G1 progression.
Consequently, PAKs may play a role in oncogenesis both by affecting cell motility and cell proliferation. However, the role of PAKs during mammalian cell cycle progression is not fully clarified.
We wanted to elucidate whether PAK1 alone is involved in cell cycle regulation. To this end, dn PAK1, wt PAK1 and ca PAK1 were induced by removal of tetracycline in mouse immortalized fibroblasts S2-6-derived clones CL8, 1A1 and 6A9, respectively (Shockett et al., 1995; Sells et al., 1999) , and cell cycle progression after synchronization by contact inhibition was analysed (Figure 1a) . Surprisingly, we found that both the dn PAK1 and the wt PAK1 inhibited cell cycle progression and that these cells could not progress through the G1 phase. Induction of ca PAK1 in the same cell line did not affect cell cycle progression. The three clones expressed reasonable levels of the respective PAK1 protein with approximately 2 times higher expression compared to the endogenous (Figure 1b) . We also transiently transfected NIH 3T3 cells and the S2-6 subline 25A3 cultured in the presence of tetracycline with myc-tagged constructs of wt PAK1, dn PAK1 and ca PAK1 (Figure 1c ) Figure 1 Overexpression of wt PAK1 and dn PAK1 inhibits cell cycle progression. (a) Expression of HA-tagged wt PAK1, dn PAK1 and ca PAK1 was induced by tetracycline removal in the 1A1, CL8 and 6A9 cell lines of modified S26 mouse fibroblasts (Shockett et al., 1995; Sells et al., 1997) that were synchronized by contact inhibition for at least 48 h (Thullberg et al., 2000) . Target proteins were induced 12 h before the cells were released to progress through the cell cycle. The cells were fixed and DNA stained with propidium iodide (PI) and the cell cycle phase distribution was analysed by flowcytometry (FACS) as described by Bakhiet et al. (2001) . The percentage of cells in the G1 phase is given above the respective DNA profile. Displayed results are representative figures out of three experiments. (b) The levels of induced proteins compared to endogenous PAK1 were determined by immunoblot using the 12CA5 anti-HA mAb, N-20 anti PAK1 pAb and b-actin as an indicator of equal loading. (c) Myc-tagged PAK1 and derivatives were transiently expressed in NIH 3T3 mouse fibroblasts and the 25A3 cell line of S26 cells cultured with tetracycline. Forty-eight hours after transfection, BrdU was added to the culture media and after 1 h cells, were fixed and stained with 9E10 mAb against the myc tag and with G3G4 mAb against BrdU. BrdU incorporation in transfected cells was analysed by fluorescence microscopy with at least 300 cells counted per condition. Expression levels of the different PAK1 constructs were similar. Shown is the average of three experiments (NIH3T3). The experiment was also repeated in 25A3 cells (right panel). Error bars indicate s.d. values and statistical analyses were performed using heteroscedastic one-tailed t-test. (Sells et al., 1999) . Forty-eight hours after transfection, we pulsed the cells with bromodeoxyuridine (BrdU) for 60 min and the fraction of transfected cells in S phase was revealed by double immunofluorescence microscopy as described in Figure 2c legend. Expression levels of the different proteins were similar (data not shown). We found that the fractions of cells in S phase were smaller in cells transfected with either dn PAK1 or wt PAK1 compared to in cells transfected with empty vector, whereas ca PAK1 had no effect on BrdU incorporation (Figure 1c) . Our results suggest that expression of inactive PAK1 inhibits cell cycle progression in contrast to active PAK1, which did not. The fact that also exponentially growing cells were affected by dn and wt PAK1 suggests that the G1-phase progression is inhibited and not the G0 to G1 transition.
Given that PAK1 also binds the small GTPases Rac and Cdc42, which were previously shown to have effects on cell cycle progression (Welsh et al., 2001) , the effects observed with the PAK1 constructs may, not only be due to a block in PAK1 signaling, but also to GTPaseinhibition and a block of their downstream signaling pathways. Consistent with this reasoning, dn PAK1 inhibited cell cycle progression more efficiently than wt PAK1 in both NIH 3T3 and in 25A3 cells (Figure 1c ). To block PAK1 activity in a different way independent of small GTPases, we used a 67-residue polypeptide derived from the PAK1 N-terminus amino acids 83-149 corresponding to the PAK1 N-terminal kinase inhibitory domain (KID) . In its inactive state, PAK1 forms homodimers where the KID on one PAK1 molecule binds to and inhibits the kinase of its counterpart in trans (Lei et al., 2000) . Expression of the glutathione-S-transferase (GST)-tagged KID inhibits PAK1 kinase activity without blocking the guanine triphosphate loading of Rac or Cdc42 both in vivo and in vitro and has been widely used as a specific inhibitor of PAK family members (Zenke et al., 1999; Lee et al., 2001; Li et al., 2001; Dadke et al., 2003; Balasenthil et al., 2004; Chi et al., 2004; DerMardirossian et al., 2004) .
We used 25A3 cells which are mouse immortalized fibroblasts S2-6 modified to express GST-KID in an inducible manner. 25A3 cells were cultured with or without the expression of GST-KID and cell cycle distribution was analysed by flow cytometry (Figure 2a and b). When we induced GST-KID in cells synchronized in G0/G1 phase by contact inhibition, the cells were unable to progress through the G1 phase within 20 h after release ( Figure 2a) . However, the cells not expressing KID had progressed through G1 phase and entered S phase (Figure 2a ). At the time of replating (0 h after release), both the cells with or without KID expression were synchronized in G0 phase to an equal extent ( Figure 2a ). To further analyse the effect of KID on the cell cycle, we induced KID in exponentially growing cells and subsequently analysed cell cycle distribution 48 h after induction. We found that KID induced an almost complete cell cycle arrest with an accumulation of cells in the G1 phase of the cell cycle. Forty-eight hours after the start of GST-KID induction, 89% of the cells were in the G1 phase, as compared to 65% of the asynchronously growing cells without induction of KID ( Figure 2b ). In addition, we expressed GST and GST-KID in NIH 3T3 mouse fibroblasts and in the COS-7 and ECV304 tumor cell lines by transient transfections and then analysed the fraction of transfected cells in S phase (Figure 2c and d). We found that KID induced a cell cycle arrest in all cells tested, indicating that KID blocks proliferation of transformed tumor cells. The fact that cells expressing KID only accumulated in the G1 phase indicated that KID blocked critical events in the G1 phase but had no effect during the S, G2 or M phases. That KID induced a cell cycle arrest when induced in exponentially growing cells indicates that the G1-phase progression is disturbed and not the G0/G1 transition. These results also indicate that the KID domain may be responsible for the cell cycle arrest enforced by wt PAK1 overexpression and that this arrest occurs independently of Cdc42 and Rac.
In order to further study the role of KID during cell cycle progression and to map the part of KID responsible for the cell cycle arrest, we constructed mammalian expression vectors expressing GST alone or GST fusion proteins with full-length KID corresponding to the 83-149 amino-acid residues in PAK1, the N-terminal half of KID (aa 83-118), the C-terminal half KID (aa 118-149), and two fragments covering the middle of KID (aa 113-133 and aa 83-133) (Figure 3a) . We expressed these constructs in 25A3 mouse fibroblasts cultured with tetracycline and analysed how many of the transfected cells were in S phase. This cell line made it possible for us to induce GST-KID by the removal of tetracycline and use this as an internal control of S-phase inhibition (data not shown). The expression levels of the different fragments and the full-length KID were similar but expression of only GST is generally much higher (data not shown). We found that only the full-length intact KID significantly blocked cell cycle progression (Figure 3a ). In addition, we used a point mutant of GST-KID to investigate whether inhibition of PAK1 was essential for the cell cycle arrest (Figure 3b and c). The point mutant KID-L107F, where the Leucine at position 107 is changed to Phenylalanine, was suggested not to inhibit PAK1 as this point mutant in the full-length PAK1 kinase creates a constitutively active kinase. The Leucine resides at the PAK1 interface and is involved in KID binding and inhibiting the C-terminal kinase domain when PAK1 is in its inactive state as a homodimer (Brown et al., 1996; Lei et al., 2000) . The KID-L107F has been frequently used as an inactive KID control in studies of PAK1 functions (Dadke et al., 2003; Balasenthil et al., 2004; Chi et al., 2004; DerMardirossian et al., 2004) . The GST-KID, GST-KID-L107F and GST alone were used in transient transfections in NIH 3T3 and in 25A3 cultured with tetracycline (Figure 3b and c) . Surprisingly, we found that expression of the GST-KID-L107F induced a cell cycle arrest to a similar degree as the GST-KID itself (Figure 3b and c) . However, in spite of higher levels of GST-KID-L107F, this construct could not efficiently inhibit the activity of PAK1 induced by Rac1 The fraction of cells transfected with the full-length GST-KID was statistically different from the GST control: P-value given in the figure according to heteroscedastic one tailed t-test, whereas the other KID fragments did not enforce any statistically significant effect. (b, c) The point mutant GST-KID-L107F incapable of inhibiting PAK1 Lei et al., 2000) was as efficient as the wild type GST-KID in inhibiting cell cycle progression in both NIH 3T3 (b) and 25A3 cells (c). Shown is one representative experiment (b) or averages of three experiments with s.d. shown as error bars and the P-values from statistical analyses by t-test indicated above the bars (c). (d) The efficiency of GST, GST-KID and GST-KID-L107F mutant to inhibit Racinduced PAK1 activity was analysed by an in vitro kinase assay. NIH 3T3 cells were transfected with the indicated DNA and PAK1 kinase activity was detected as 32 P-incorporation to myelin basic protein as a substrate essentially as described (Sells et al., 1999) , upper panel. Quantification was made by phosphorimager (cyclon server, Packard) with the quantiquest software and given as DLU/mm 2 arbitrary units, below. Expression levels of transfected proteins were evaluated by immunoblot from the same lysates, middle. The input plasmids indicated, below. (e) GST-KID was induced in 25A3 cells, which were transiently transfected with an empty vector (v), ca PAK1, wt PAK1 or dn PAK1. Vector-tranfected cells grown with tetracycline (v þ tet) served as control. The fraction of cells in S phase was determined by immostaining of BrdU incorporation in transfected cells as described above, upper panel. Middle panel shows an in vitro kinase assay with quantification as above, where ca PAK1 has high kinase activity even though GST-KID is expressed. The immunoblot illustrates equal expression of tranfected proteins.
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M Thullberg et al (Figure 3d ), verifying the inability of this mutant to affect PAK1 activity (Zenke et al., 1999; Dadke et al., 2003; DerMardirossian et al., 2004) . To clarify whether the KID and PAK1 may act within the same molecular pathway in block of cell proliferation, we investigated if ca PAK1 could rescue the cell cycle arrest enforced by KID. We hypothesized that if KID induces a cell cycle block by binding and inhibiting PAK1 and/or hits the same molecular pathway as PAK1 kinase activity, then the ca PAK1 would be able to rescue this block. We transfected 25A3 cells with dn PAK1, wt PAK1 and ca PAK1 together with the expression of GST-KID and analysed the fraction of transfected cells that were in S phase (Figure 3e) . Unexpectedly, but consistent with our results using the KID-mutant, expression of ca PAK1 did not rescue the cell cycle arrest induced by GST-KID. However, it was not obvious that the ca PAK1 mutant should render a PAK1 kinase that was resistant to the inhibition by KID. To test this, we transfected a myc-tagged ca PAK1 into 25A3 cells with or without the induction of GST-KID and measured the kinase activity (Figure 3e ). The in vitro kinase assay showed that ca PAK1 is equally active with or without the expression of KID and consequently demonstrated that KID did not inhibit ca PAK1, unless KID dissociated from ca PAK1 in vitro. Dn PAK1 was used as a negative control and compared with wt PAK1 (Sells et al., 1997) . Consistent with previous reports, we found that expression of the KID inhibited the kinase activity of wt PAK1 (Figure 3d-e) , although the inhibition was not very dramatic using wt PAK1 alone that displays low activity without the coexpression of Rac or Cdc42 (compare Figure 3d and e). Taken together, our results indicate firstly that KID has a target separate from PAK1 and secondly, that this target does not reside upstream of PAK1 kinase activity in PAK1 signaling pathways controlling cell proliferation.
The D-type cyclins are normally induced in the early G1 phase and this accumulation is a prerequisite for G1 phase progression (Bartek et al., 1999) . Therefore, we investigated whether the expression of KID might affect cyclin D protein levels. We used cells synchronized in the G0/G1 phase and released them with or without KID and analysed the levels of cyclin D1 and cyclin D2 by immunoblotting within 24 h after release (Figure 4a ). The cells without KID progressed normally through the cell cycle and induced cyclin D1 and D2 during G1-phase progression with detectable levels already 4 h after restart but with increased levels throughout the time course of observation, with the highest cyclin D1 and D2 levels 24 h after release (Figure 4a ). In contrast, the cells expressing KID did not induce any detectable D-type cyclins within 24 h after release (Figure 4a) . Interestingly, the expression of KID did not reduce the levels of activated extracellular signal-regulated kinase (ERK) 1/2 nor activated AKT (S-473-PO4), suggesting that the downregulation of cyclin D1 was not mediated through these signalling molecules (Figure 4a ). To control that KID was expressed after induction in these cells, we analysed the protein levels of GST-KID during the experiment. Indeed, GST-KID could not be detected in the cells grown with tetracycline, but was heavily expressed in the cells cultured without tetracycline (Figure 4a) . Similarly, in 1A1 cells expressing wt PAK1, there was a significant decrease in cyclin D1 levels with no change in the levels of activated ERK 1/2 (Figure 4b) . However, the expression of ca PAK1 had no reducing effect on cyclin D1 levels (data not shown), consistent with its lack of cell cycle inhibitory activity (Figure 1a) . We also analysed cyclin D1 levels in cells expressing KID combined with ca PAK1 and found no detectable increase of cyclin D1 by immunoblot (data not shown).
To investigate whether the KIDL107F mutant had a comparable impact on cyclin D1 levels, we transiently expressed wt KID and the mutant KIDL107F in 25A3 cells and analysed cyclin D1 levels by immunofluorescence (Figure 4c ). We found fewer cells with cyclin D1 in cells expressing any of the KID constructs compared to GST alone (Figure 4c ). Differences in detection levels may explain why 8-10% of cells have detectable cyclin D1 by immunofluorescence, while we cannot detect cyclin D1 in KID-expressing cells by immunoblot (Figure 4a and c) . Our results suggest that the KID mutant induced cell cycle arrest with low cyclin D1 levels similar to the KID wt. To test the function of the KID regulation of cyclin D in the accompanying cell cycle arrest, GST-KID expression by removal of tetracycline was combined with transient transfection of cyclin D1 in 25A3 cells (Figure 4d ). In fact, cyclin D1 overexpression rescued cell proliferation in the presence of GST-KID (Figure 4d ). With cyclin D1 expressed, we could detect 11% of the cells in S phase compared to 1.5% in vector-transfected cells. Given that the transient cyclin D1 transfection rate was 35% and the fraction of cell in S phase in the control not expressing KID was 32%, implicates that the maximum fraction of rescued cells could be 35% out of 32, which equals 11%. Our data shows that expression of cyclin D1 could impose a complete rescue of the cell cycle arrest enforced by KID. Together, this shows that the KID-enforced block of cyclin D provides a functional mechanism for the observed cell cycle inhibition. Because cyclin D1 alone cannot push cell cycle progression from G0 (Resnitzky et al., 1994) , this result also demonstrate that expression of GST-KID induces a G1-phase arrest. Our results further suggest that the KID region in wt PAK1 could act by a similar mechanism to suppress cell cycle G1 phase with downregulation of cyclin D1.
This study shows that the KID of PAK1 inhibits cell cycle progression and arrests cells in the G1 phase. Furthermore, we show that the KID-mediated cell cycle arrest occurs independently of inhibition of PAK1 kinase activity. Importantly, the GST-tagged KID peptide has been used in many functional studies investigating the role of PAK kinases Zenke et al., 1999; Adam et al., 2000; Lee et al., 2001; Li et al., 2001; Dadke et al., 2003; Balasenthil et al., 2004; Chi et al., 2004; DerMardirossian et al., 2004) . However, our finding that KID may have other PAK1 kinase-inhibitory domain induces cell cycle arrest M Thullberg et al targets than PAK1-3 illuminates the fact that precautions must be taken when interpreting the results of such studies. The observation that KID arrested cells in the G1 phase demands further precautions interpreting results from studies using this inhibitor, as signal transduction might be very different in a G1 phasearrested cell compared to a cycling cell.
We hypothesize that KID may bind to and inhibit other target(s) important for G1-phase progression and thereby either inhibits the transcription of D-type (Bakhiet et al., 2001) . Shown is average of 3 experiments with s.d. error bars. The difference between cyclin D1-transfected and vector-transfected cells when KID was expressed was statistically significant as determined by student's t-test. Analysis of cotransfected GFP showed that the average transfection efficiency was 35% for the three experiments. The rescue observed of 11% corresponds to what would be expected in the case of a complete rescue, when comparing to the 32% of cells in S phase in the controls without KID and considering the transfection efficiency. The immunoblot shows one representative experiment with expression of cyclin D1 and GST-KID and beta-actin as control of equal loading.
PAK1 kinase-inhibitory domain induces cell cycle arrest M Thullberg et al cyclins or enhances the degradation of those cyclins. One such candidate target might be CIB 1, a Ca 2 þ and kinase binding protein that interacts with PAK1 in the KID (Leisner et al., 2005) . Importantly, loss of G1-phase control has been shown to be fundamental during cancer development and expression of several tumor suppressors enforces a G1-phase arrest. This study shows that KID is able to block cell proliferation also of cancer cells. The 67 amino-acid long peptide of KID might therefore be useful to inhibit tumor growth if transduced or expressed in tumor cells.
An interesting question is whether the KID region in its normal environment as a part of PAK1 equally inhibits the cell cycle. In fact, our findings support this hypothesis. KID as a peptide imposed a solid G1-phase arrest and also dn PAK1 and wt PAK1 inhibited cell cycle progression with accompanying inhibition of cyclin D expression (Figure 4b and data not shown). However, ca PAK1 did not affect the cell cycle nor cyclin D1 levels (Figure1a and data not shown). The differential effects by different PAK1 constructs might be due to the different PAK1 conformations formed within cells where only certain conformations expose the KID in PAK1 to the putative cell cycle regulator. The conformation of PAK1 can be regulated by autophosphorylation, lipid binding as well as binding to small GTPases (Lei et al., 2000; Chong et al., 2001) . Also PAK1, in most inhibited states, forms homodimers where the KID might not be accessible to other proteins than PAK1 (Lei et al., 2000; Parrini et al., 2002) . This might explain the fact that the isolated KID had a much more pronounced effect on the cell cycle as compared to wt PAK1 and dn PAK1. Thus, in the physiological situation, it is likely that only a fraction of the PAK1 has an exposed KID that could bind to other proteins and thereby inhibit the cell cycle. In addition, phosphorylated PAK1 may not be accessible for the putative cell cycle regulator, as ca PAK1 did not inhibit cell cycle progression. Although we found that the isolated KID domain of PAK1 causes cell cycle arrest, we cannot rule out additional mechanisms for the cell cycle inhibition by wt PAK1 and dn PAK1. PAK1 contains several protein-protein interaction domains, and interacts with proteins like PIX and Nck in addition to its Cdc42 and Rac binding, and also has proven functions as scaffold (Manser et al., 1994 Bokoch et al., 1996; Galisteo et al., 1996; Thiel et al., 2002; Li et al., 2003; SundbergSmith et al., 2005) . In fact, two recent studies show that PAK1 is necessary for cell cycle progression (Balasenthil et al., 2004; Nheu et al., 2004) . In addition, three studies show that ca PAK1 induces transcription of cyclin D1 promotor (Dadke et al., 2003; Balasenthil et al., 2004; Chi et al., 2004) .Considering also our findings, PAK1 may have both cell cycle promoting and inhibiting properties and the levels of phosphorylated active versus inactive PAK1 might finetune this function. It is also possible that PAK1 may regulate cyclin D1 both at transcriptional and post-transcriptional levels.
In summary, we found that KID inhibits cell cycle progression independent of inhibition of PAK1 kinase activity, which demands serious precautions when using this peptide for investigating PAK1 functions. We suggest that KID and the KID domain in PAK1 may interact with a critical cell cycle regulator important for G1-phase progression through promotion of D-type cyclin expression.
